FDA found Yongdae Hwangtae Union's raw ready-to-eat dried pollack exposed outdoors and its seafood hazard-control plan inadequate for pathogens and allergens.
What happened
FDA inspected the seafood processing facility on June 27-28, 2024 and issued a Form FDA-483, a list of inspection observations. FDA found the firm air-dries pollack outdoors on stakes in winter, stores it refrigerated with unknown water activity, and uses a HACCP (hazard-control) plan with inadequate critical limits and corrective actions for pathogen growth and toxin formation. FDA also found the HACCP plan does not list undeclared finfish allergen.
What FDA found
The firm air-dries pollack outdoors on stakes, exposing a raw ready-to-eat food to filth and pathogens such as bird and insect contamination.
21 CFR 117.80(a) and (b); 21 CFR 123.6(a) and (b)The HACCP plan's critical limit at the drying critical control point does not ensure the finished product reaches a water activity low enough to control pathogens including Clostridium botulinum.
21 CFR 123.6(c)(3)The HACCP plan allows cumulative unrefrigerated processing time that is too long to control pathogen growth and toxin formation.
21 CFR 123.6(c)(3)The corrective actions only say to redry or discard product and do not correct the cause of the deviation, such as oven adjustments or procedure changes.
21 CFR 123.7(b)The hazard analysis and HACCP plan for dried pollack do not list undeclared finfish (pollack) allergen as a food safety hazard.
21 CFR 123.6(a) and (c)(1)
What FDA wants
FDA asks the firm to respond in writing within 15 working days with corrective actions, a revised HACCP plan with supporting documentation, and at least five days of critical-control-point and sanitation monitoring in English.
Who should pay attention
- US importers and distributors of Korean seafood
- brands or retailers selling ready-to-eat dried pollack
- seafood processors using outdoor drying or reduced-oxygen packaging
This is a summary. Read the original letter on fda.gov.